Recent Articles

August 3, 2015 9:11 am
Ryan Bushey, Associate Editor
Scientists taking part in the investigation tested the drug on 4,000 people with close ties to Ebola patients. Read more...
July 31, 2015 9:31 am
Fiona Chisholm, Associate Analyst, GBI Research
More recently approved drug classes have already achieved considerable uptake and are expected to increase their market share over the forecast period. Read more...
July 30, 2015 3:15 pm
Gianfranco Zeppetelli, Deals Analyst, GlobalData
Teva's bid for Allergan’s generics business illustrates that it has given up on its pursuit of rival Mylan NV. Read more...
July 29, 2015 9:39 am
Lindsay Hock, Editor
Now, (July/August) is the time frame when flu vaccines start to be delivered to protect the public for next year. Yet, the road to an efficient vaccine is a difficult one. Just as with any virus, influenza mutates in its genetic material, potentially causing changes in the strains present each year. Read more...
July 29, 2015 10:13 am
Cynthia Fox, Science Editor
Gene therapy restored vision to blind patients by strengthening visual pathways from the retina, through the brain’s white matter, into the brain’s visual cortex, says a report in Science Translational Medicine. Read more...
July 29, 2015 10:15 am
Nurry Hong, Managing Director; Sue St. Sure, Managing Director; and Max Cambras, Life Sciences Expert, Manager, of L.E.K. Consulting
With the rise of biologics, drug delivery presents new challenges as many companies are still taking a fragmented approach, resulting in delayed (or suboptimal) product launches and life cycle management. The problem is that it’s extremely difficult, if not impossible, to fix drug delivery challenges after the fact, so companies need a clear strategy in advance. Read more...
July 28, 2015 3:26 pm
Lindsay Hock, Editor
 Little do we think of the testing behind the medications prescribed to us that improve the quality of our lives. Yet, stringent testing is needed for any pharmaceutical or health care product to hit the shelves of your local convenience store. Read more...
July 28, 2015 3:55 pm
Cai Xuan, Ph.D., Oncology and Hematology, GlobalData
This observation opens up a market for companion biomarker tests that can be used to identify patients who would likely benefit from PD-1/PD-L1-targeted therapies. Read more...
July 27, 2015 10:40 am
Ryan Bushey, Associate Editor
The test is able to diagnose the virus in 15 minutes. Read more...
July 21, 2015 3:55 pm
Andrew S. Thompson, Ph.D., Senior In Vitro Diagnostics Analyst, GlobalData
Other significant drivers of cancer companion diagnostics market growth include increasing disease incidence, accelerating demand for targeted therapies and economic pressures to develop maximally efficient treatments. Read more...
Subscribe to Drug Discovery & Development